Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
John Carpenter
Professor Emeritus
Close
E-mail
jtc@uab.edu
Visualizations
Co-author Network
Map of Science
Co-investigator Network
John Carpenter
Professor Emeritus
Positions
Professor - Emeritus (P)
,
Medicine - Hematology & Oncology
,
Department of Medicine
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2018
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008
.
Breast Cancer Research and Treatment
. 167:107-116.
2018
2014
How do i recommend extended adjuvant hormonal therapy?
.
Current Treatment Options in Oncology
. 15:55-62.
2014
2014
TBCRC 018: Phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
.
Breast Cancer Research and Treatment
. 146:557-566.
2014
2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: Results from the I-SPY 1 TRIAL - CALGB 150007/150012, ACRIN 6657
.
Journal of Clinical Oncology
. 30:3242-3249.
2012
2012
Chemotherapy response and recurrence-free survival in Neoadjuvant breast cancer depends on biomarker profiles: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
.
Breast Cancer Research and Treatment
. 132:1049-1062.
2012
2011
An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events.
.
Journal of Clinical Oncology
. 29:121.
2011
2011
Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer.
.
Journal of Clinical Oncology
. 29:e11048.
2011
2010
Pilot trial of preoperative (Neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor-or progesterone receptor-positive breast cancer
.
Clinical Breast Cancer
. 10:275-280.
2010
2006
Safety and effectiveness of dose dense neoadjuvant chemotherapy in patients with stage II/III breast cancer.
.
Journal of Clinical Oncology
. 24:10622.
2006
1998
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: Implication for 5-fluorouracil-based chemotherapy
.
Clinical Cancer Research
. 4:325-329.
1998
1995
The use of anthracyclines in the adjuvant treatment of breast cancer.
.
Cancer Treatment Reviews
. 21:199-214.
1995
1992
Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) trial
.
European journal of cancer
. 28:1833-1837.
1992
1991
Epithelioid hemangioendothelioma: Ct manifestations and possible linkage to vinyl chloride exposure
1991
1991
Severe 5‐fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome
.
Cancer
. 68:499-501.
1991
1991
Weight gain with breast cancer adjuvant treatment
.
Cancer
. 67:1954-1959.
1991
1988
The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia.
.
Cancer
. 62:2042-2046.
1988
1988
Phase I-II study of cisplatin, VP-16, MGBG, mitomycin, and vinblastine with radiation therapy for non-small-cell lung cancer.
1988
1988
A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer
.
Journal of Clinical Oncology
. 6:1397-1400.
1988
1988
Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity
.
Journal of Clinical Investigation
. 81:47-51.
1988
1988
In Reply
.
Archives of Surgery
. 123:914.
1988
1987
Does Radical Mastectomy Still Have a Place in the Treatment of Primary Operable Breast Cancer?
.
Archives of Surgery
. 122:1317-1320.
1987
1986
Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: A Southeastern Cancer Study Group trial
.
Cancer treatment reports
. 70:1221-1223.
1986
1985
Intrarenal chloroma causing obstructive nephropathy: CT characteristics
1985
1984
Methods of nutritional support for hospitalized patients
.
American Family Physician
. 29:215-220.
1984
1983
A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients
.
Annals of Surgery
. 198:207-212.
1983
1981
The importance of leukopenia in breast cancer adjuvant therapy with melphalan (MPL)
.
Proceedings of the American Association for Cancer Research
. Vol. 22.
1981
1979
Splenectomy for hematologic disease
.
Surgery, gynecology & obstetrics
. 149:509-512.
1979
1979
A consultant-extender system for breast cancer adjuvant chemotherapy
.
Annals of Internal Medicine
. 90:396-401.
1979
1978
Agranulocytosis Associated With Disopyramide Therapy
1978
1974
Central nervous system complications after combination treatment with adriamycin (NSC 123127) and 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamide (NSC 45388)
.
CANCER CHEMOTHER.REP.
. 58:753-754.
1974
Chapter
Filter
Year
Title
Altmetric
2014
Systemic treatment of cancer with low and safe levels of radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies
. 299-305.
2014
Research
Principal Investigator On
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients with Triple-Negative Locally Advanced Breast Cancer
awarded by
VANDERBILT UNIVERSITY
Private Grant
awarded by
Genentech
Private Grant
awarded by
JANSSEN SERVICES, LLC
Private Grant
awarded by
F.Hoffmann-La Roche Ltd.
UAB 1017/TBCRC 008: A Multi-Institutional Double-Blind Phase II Study Evaluating Response and Surrogate Biomarkers to Carboplatin and nab-Paclitaxel (CP)With or Without Vorinostat as Preoperative Chemotherapy in HER-2 Negative Primary Operable Breast Cancer
awarded by
Johns Hopkins University
UAB 1017/TBCRC 008:A Multi-Institutional Double-Blind Phase II Study Evaluating Response and Surrogate Biomarkers to Carboplatin and Nab-Paclitaxel (CP) With or Without Vorinostat as Preoperative Chemotherapy in Her2-Negative Primary Operable Breast Cancer
awarded by
Johns Hopkins University
UAB 1033/TBCRC 018: A Phase II Study of the PARP Inhibitor, INIPARIB (BSI-201) in Combination with Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
awarded by
University of North Carolina at Chapel Hill
Investigator On
Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer
awarded by
UNIVERSITY OF TEXAS (M.D. ANDERSON CANCER CENTER)
Targeting Signal Transduction Pathways for the Treatment and Prevention of Breast Cancer
awarded by
UNIVERSITY OF TEXAS (M.D. ANDERSON CANCER CENTER)
UAB 1052-TBCR020: The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed with Lobular Neoplasia of the Breast by Core Needle Biopsy
awarded by
Johns Hopkins University
Background
Education And Training
Doctor of Medicine,
Tulane University
1968
Contact
Full Name
John
Carpenter